Stay updated on Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page
- Check2 days agoChange DetectedThe page's software revision indicator was updated from v3.6.4 to v3.6.5, signaling a behind-the-scenes update rather than a change to study information.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPage revision updated from v3.6.3 to v3.6.4, indicating a new version of the page/template. This appears to be a small maintenance update rather than a substantive change to the study information.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now displays revision: v3.6.3. This appears to be a minor update to the page version rather than a substantive change to the trial details.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe recruitment status was updated to indicate that this study is no longer looking for participants. Other changes relate to page navigation and labeling (e.g., new sections like 'How to Read a Study Record' and 'How to Join a Study', as well as heading formatting and revision notes), which affect how the page is navigated but do not alter the core study data.SummaryDifference0.4%

- Check67 days agoChange Detected- Revision updated from v3.5.4 to v3.5.5, indicating a small update to the page's metadata/formatting rather than to the study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Colorectal Cancer Clinical Trial page.